Literature DB >> 32997602

Novel Therapeutic Approach for Excitatory/Inhibitory Imbalance in Neurodevelopmental and Neurodegenerative Diseases.

Swagata Ghatak1, Maria Talantova1, Scott R McKercher1, Stuart A Lipton1,2.   

Abstract

Excitatory/inhibitory (E/I) balance, defined as the balance between excitation and inhibition of synaptic activity in a neuronal network, accounts in part for the normal functioning of the brain, controlling, for example, normal spike rate. In many pathological conditions, this fine balance is perturbed, leading to excessive or diminished excitation relative to inhibition, termed E/I imbalance, reflected in network dysfunction. E/I imbalance has emerged as a contributor to neurological disorders that occur particularly at the extremes of life, including autism spectrum disorder and Alzheimer's disease, pointing to the vulnerability of neuronal networks at these critical life stages. Hence, it is important to develop approaches to rebalance neural networks. In this review, we describe emerging therapies that can normalize the E/I ratio or the underlying abnormality that contributes to the imbalance in electrical activity, thus improving neurological function in these maladies.

Entities:  

Keywords:  NMDA receptor antagonists; NMDA receptors; NitroSynapsin; excitatory/inhibitory imbalance; neurological disorders

Year:  2020        PMID: 32997602     DOI: 10.1146/annurev-pharmtox-032320-015420

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  9 in total

Review 1.  Towards development of disease-modifying therapy for Alzheimer's disease using redox chemical biology pathways.

Authors:  Stuart A Lipton
Journal:  Curr Opin Pharmacol       Date:  2022-07-20       Impact factor: 4.768

Review 2.  Keeping Excitation-Inhibition Ratio in Balance.

Authors:  Sergei Kirischuk
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

3.  STXBP1 Syndrome Is Characterized by Inhibition-Dominated Dynamics of Resting-State EEG.

Authors:  Simon J Houtman; Hanna C A Lammertse; Annemiek A van Berkel; Ganna Balagura; Elena Gardella; Jennifer R Ramautar; Chiara Reale; Rikke S Møller; Federico Zara; Pasquale Striano; Mala Misra-Isrie; Mieke M van Haelst; Marc Engelen; Titia L van Zuijen; Huibert D Mansvelder; Matthijs Verhage; Hilgo Bruining; Klaus Linkenkaer-Hansen
Journal:  Front Physiol       Date:  2021-12-23       Impact factor: 4.566

4.  Neurotransmitter-stimulated neuron-derived sEVs have opposite effects on amyloid β-induced neuronal damage.

Authors:  Yunxiao Dou; Junchao Xie; Yan Tan; Min Zhang; Yanxin Zhao; Xueyuan Liu
Journal:  J Nanobiotechnology       Date:  2021-10-15       Impact factor: 10.435

Review 5.  Interneuron Dysfunction and Inhibitory Deficits in Autism and Fragile X Syndrome.

Authors:  Toshihiro Nomura
Journal:  Cells       Date:  2021-10-01       Impact factor: 6.600

Review 6.  Excitation/Inhibition Modulators in Autism Spectrum Disorder: Current Clinical Research.

Authors:  Roberto Canitano; Roberto Palumbi
Journal:  Front Neurosci       Date:  2021-11-30       Impact factor: 4.677

7.  Integrated Excitatory/Inhibitory Imbalance and Transcriptomic Analysis Reveals the Association between Dysregulated Synaptic Genes and Anesthetic-Induced Cognitive Dysfunction.

Authors:  Yasheng Yan; Sarah Logan; Xiaojie Liu; Bixuan Chen; Congshan Jiang; Thiago Arzua; Ramani Ramchandran; Qing-Song Liu; Xiaowen Bai
Journal:  Cells       Date:  2022-08-11       Impact factor: 7.666

8.  An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD.

Authors:  Claudia S Bauer; Rebecca N Cohen; Francesca Sironi; Matthew R Livesey; Thomas H Gillingwater; J Robin Highley; Daniel J Fillingham; Ian Coldicott; Emma F Smith; Yolanda B Gibson; Christopher P Webster; Andrew J Grierson; Caterina Bendotti; Kurt J De Vos
Journal:  Acta Neuropathol       Date:  2022-07-25       Impact factor: 15.887

Review 9.  Dysregulation of GABAergic Signaling in Neurodevelomental Disorders: Targeting Cation-Chloride Co-transporters to Re-establish a Proper E/I Balance.

Authors:  Enrico Cherubini; Graziella Di Cristo; Massimo Avoli
Journal:  Front Cell Neurosci       Date:  2022-01-05       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.